These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 31230892

  • 1. Traditional Chinese Medicine Treatment as Adjuvant Therapy in Completely Resected Stage IB-IIIA Non-Small-Cell Lung Cancer: Study Protocol for a Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial.
    Jiang Y, Liu LS, Shen LP, Liu JX, Jiang GN, Gu AQ, Li HC, Li Q, Li HG, Huang PX.
    Clin Lung Cancer; 2019 Sep; 20(5):e541-e547. PubMed ID: 31230892
    [Abstract] [Full Text] [Related]

  • 2. The effect of comprehensive rehabilitation program plus chemotherapy on quality of life in patients with postoperative non-small-cell lung cancer: study protocol of a multicenter randomized clinical trial.
    Yao J, Jiao L, Yao Y, Lu Y, Shi J, Li J, Chen P, Xu L, Gong Y.
    Trials; 2020 Apr 03; 21(1):309. PubMed ID: 32245480
    [Abstract] [Full Text] [Related]

  • 3. A randomized phase II study of S-1 monotherapy versus cisplatin with vinorelbine for completely resected stage II/IIIA non-small cell lung cancer: rationale and study protocol design for the LOGIK1702 study.
    Tsuchiya T, Matsumoto K, Miyazaki T, Doi R, Tokunaga S, Yamaguchi H, Tomoshige K, Watanabe H, Nagayasu T, Sugio K.
    BMC Cancer; 2021 Mar 08; 21(1):249. PubMed ID: 33685421
    [Abstract] [Full Text] [Related]

  • 4. Effects of traditional Chinese medicine combined with chemotherapy for extensive-stage small-cell lung cancer patients on improving oncologic survival: study protocol of a multicenter, randomized, single-blind, placebo-controlled trial.
    Chen Y, Yu M, Liu Z, Zhang Y, Li Q, Yang G.
    Trials; 2021 Jul 08; 22(1):437. PubMed ID: 34238342
    [Abstract] [Full Text] [Related]

  • 5. Chemotherapy in conjunction with traditional Chinese medicine for survival of elderly patients with advanced non-small-cell lung cancer: protocol for a randomized double-blind controlled trial.
    Zhou ZY, Xu L, Li HG, Tian JH, Jiao LJ, You SF, Han ZF, Jiang Y, Guo HR, Liu H.
    J Integr Med; 2014 May 08; 12(3):175-81. PubMed ID: 24861837
    [Abstract] [Full Text] [Related]

  • 6. Traditional Chinese Medicine treatment as maintenance therapy in advanced non-small-cell lung cancer: A randomized controlled trial.
    Jiang Y, Liu LS, Shen LP, Han ZF, Jian H, Liu JX, Xu L, Li HG, Tian JH, Mao ZJ.
    Complement Ther Med; 2016 Feb 08; 24():55-62. PubMed ID: 26860802
    [Abstract] [Full Text] [Related]

  • 7. A multicenter randomized controlled trial to assess the efficacy of cancer green therapy in treatment of stage IIIb/IV non-small cell lung cancer.
    Sun M, Zhou T, Fang X, Wang D, Pang H, Chen Y, Hu K.
    Medicine (Baltimore); 2020 Aug 14; 99(33):e21626. PubMed ID: 32872022
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A randomized phase II study to assess the effect of adjuvant immunotherapy using α-GalCer-pulsed dendritic cells in the patients with completely resected stage II-IIIA non-small cell lung cancer: study protocol for a randomized controlled trial.
    Saka H, Kitagawa C, Ichinose Y, Takenoyama M, Ibata H, Kato T, Takami K, Yamashita M, Maeda T, Takeo S, Ueda H, Okabayashi K, Nagashima S, Oka T, Kouso H, Fukuyama S, Yoshimoto K, Shimokawa M, Saito AM, Ito S.
    Trials; 2017 Sep 15; 18(1):429. PubMed ID: 28915900
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of Shengjiang Xiexin decoction in prophylaxis of chemotherapy-related diarrhea in small cell lung cancer patients: study protocol for a multicenter randomized controlled trial.
    Deng C, Lou Y, Gao Y, Deng B, Su F, Jia L.
    Trials; 2020 May 01; 21(1):370. PubMed ID: 32357899
    [Abstract] [Full Text] [Related]

  • 13. Effects of Chinese Medicine as Adjunct Medication for Adjuvant Chemotherapy Treatments of Non-Small Cell Lung Cancer Patients.
    Jiao L, Dong C, Liu J, Chen Z, Zhang L, Xu J, Shen X, Che J, Yang Y, Huang H, Li H, Sun J, Jiang Y, Mao Z, Chen P, Gong Y, Jin X, Xu L.
    Sci Rep; 2017 Apr 24; 7():46524. PubMed ID: 28436479
    [Abstract] [Full Text] [Related]

  • 14. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.
    Strauss GM, Herndon JE, Maddaus MA, Johnstone DW, Johnson EA, Harpole DH, Gillenwater HH, Watson DM, Sugarbaker DJ, Schilsky RL, Vokes EE, Green MR.
    J Clin Oncol; 2008 Nov 01; 26(31):5043-51. PubMed ID: 18809614
    [Abstract] [Full Text] [Related]

  • 15. Combination of first-line chemotherapy with Kanglaite injections versus first-line chemotherapy alone for advanced non-small-cell lung cancer: study protocol for an investigator-initiated, multicenter, open-label, randomized controlled trial.
    Gao R, Zhang Y, Hou W, Li J, Zhu G, Zhang X, Xu B, Wu Z, Wang H.
    Trials; 2021 Mar 17; 22(1):214. PubMed ID: 33731199
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Yifei Sanjie Formula or Placebo With Anlotinib as Second-Line or Above Treatment for Metastatic Non-Small-Cell Lung Cancer: Study Protocol for a Double-Blind, Placebo-Controlled Randomized Pilot Study.
    Chen W, Lin J, Yang T, Xin Zhang Z, Tao L, Xiao Z, Chen H, Qi X, Sun L, Cao Y, Lin L.
    Integr Cancer Ther; 2023 Mar 17; 22():15347354221151147. PubMed ID: 36710490
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of Jianpishengsui for chemotherapy-related fatigue in patients with non-small cell lung cancer: study protocol for a randomized placebo-controlled clinical trial.
    Xiao Z, Hu L, Lin J, Lu L, Huang X, Zhu X, Teo C, Lin L.
    Trials; 2020 Jan 16; 21(1):94. PubMed ID: 31948475
    [Abstract] [Full Text] [Related]

  • 19. Fuzheng Kang'ai decoction combined with gefitinib in advanced non-small cell lung cancer patients with epidermal growth factor receptor mutations: study protocol for a randomized controlled trial.
    Yang XB, Wu WY, Long SQ, Deng H, Pan ZQ, He WF, Zhou YS, Liao GY, Li QP, Xiao SJ, Cai JZ.
    Trials; 2015 Apr 10; 16():146. PubMed ID: 25873045
    [Abstract] [Full Text] [Related]

  • 20. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
    Logan DM, Lochrin CA, Darling G, Eady A, Newman TE, Evans WK.
    Cancer Prev Control; 1997 Dec 10; 1(5):366-78. PubMed ID: 9765759
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.